As the calendar year 2024 draws to a close, the primary market continues its stellar run with a flurry of activity. Amongst the three mainboard IPOs that are going to list today (December 30), two issues are in the spotlight – Senores Pharmaceuticals and Ventive Hospitality with much speculation on which issue might deliver better gains.
Although both companies come from different sectors and carry their own market dynamics, let’s take a look at the key details of the issue and their potential listing performance.
Grey Market Premium: What Does It Indicate?
The grey market premium (GMP) is often seen as an early indicator of investor sentiment.
As per the recent trend, prior to some hours before the official listing of the company, the shares of Senores Pharmaceuticals has been trading at a GMP of Rs 284, suggesting a possible listing price of Rs 675 per share, a 72.63 per cent higher than its upper price band of Rs 391. Furthermore, it is also important to note that over the past two weeks, its GMP has consistently remained strong.
On the other side, Ventive Hospitality’s GMP is relatively subdued at Rs 70. This translates to an estimated listing price of Rs 713 per share, which is 10.89 per cent higher than its IPO price of Rs 643.
However, it is important to note that GMP is just an indicator of market sentiment and not a guarantee of the actual listing price or future performance of the stock.
Lot Size
Now coming to the lot size, for retail investors, the minimum investment in the Senores Pharmaceuticals IPO starts at Rs 14,858 for one lot of 38 shares. Small High Net Worth Individuals (sNII) must apply for at least 14 lots, equivalent to Rs 2,08,012, while large NIIs (bNII) need to bid for at least 68 lots, amounting to Rs 10,10,344.
Ventive Hospitality, on the other hand, requires retail investors to shell out Rs 14,789 for one lot of 23 shares. For sNIIs, the minimum application involves 14 lots (Rs 2,07,046), while bNIIs must apply for at least 68 lots, which totals Rs 10,05,652.
Subscription Numbers
Senores Pharmaceuticals has set the bar high with a subscription rate of 97.86 times with retail investors subscribing 93.16 times, while QIBs and NIIs subscribed 97.84 and 100.35 times, respectively.
Ventive Hospitality, in the three day bidding period garnered a subscription rate of 10.33 times where retail investors subscribed 6.19 times, while QIBs and NIIs subscribed 9.58 and 14.6 times, respectively.
Anchor Investor Participation and Management
Both IPOs have secured significant anchor investments. Senores Pharmaceuticals raised Rs 260.63 crore from anchor investors, with Equirus Capital, Ambit, and Nuvama Wealth acting as lead managers. On the other side, Ventive Hospitality raised a more substantial Rs 719.55 crore from anchor investors, with a consortium of lead managers that includes JM Financial, Axis Capital, and Kotak Mahindra Capital.